Endogenous murine tau promotes neurofibrillary tangles in 3xTg-AD mice without affecting cognition

Neurobiology of Disease

Volumn 62, Issue , 2014, Pages 407-415

  Baglietto Vargas, David ^a   Kitazawa, Masashi ^a,b   Le, Elaine J ^a   Estrada Hernandez, Tatiana ^a   Rodriguez Ortiz, Carlos J ^a,b   Medeiros, Rodrigo ^a   Green, Kim N ^a   LaFerla, Frank M ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

3xTg AD mice; Alzheimer's disease; Hippocampus; Neurofibrillary tangles; Tau

Indexed keywords

CYCLIN DEPENDENT KINASE 5; PROTEIN P25; TAU PROTEIN;

ALZHEIMER DISEASE; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; COGNITION; COGNITIVE DEFECT; CONTROLLED STUDY; DISEASE MODEL; GENE DELETION; MOUSE; NEUROFIBRILLARY TANGLE; NONHUMAN; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN AGGREGATION; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; SENILE PLAQUE; SPATIAL MEMORY; TASK PERFORMANCE; TRANSGENIC MOUSE;

3XTG-AD MICE; ALZHEIMER'S DISEASE; HIPPOCAMPUS; NEUROFIBRILLARY TANGLES; TAU;

ALZHEIMER DISEASE; AMYLOID BETA-PEPTIDES; AMYLOID BETA-PROTEIN PRECURSOR; ANIMALS; COGNITION; FEMALE; HIPPOCAMPUS; HUMANS; MALE; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; NEUROFIBRILLARY TANGLES; PHOSPHORYLATION; TAU PROTEINS;

EID: 84887558401     PISSN: 09699961     EISSN: 1095953X     Source Type: Journal    
DOI: 10.1016/j.nbd.2013.10.019     Document Type: Article

References (39)

1. Ando K., et al. Deletion of murine tau gene increases tau aggregation in a human mutant tau transgenic mouse model. Biochem. Soc. Trans. 2010, 38:1001-1005.
2. Ando K., et al. Accelerated human mutant tau aggregation by knocking out murine tau in a transgenic mouse model. Am. J. Pathol. 2011, 178:803-816.
3. Andorfer C., et al. Hyperphosphorylation and aggregation of tau in mice expressing normal human tau isoforms. J. Neurochem. 2003, 86:582-590.
4. Andorfer C., et al. Cell-cycle reentry and cell death in transgenic mice expressing nonmutant human tau isoforms. J. Neurosci. 2005, 25:5446-5454.
5. Baglietto-Vargas D., et al. Mifepristone alters amyloid precursor protein processing to preclude amyloid beta and also reduces tau pathology. Biol. Psychiatry 2013, 74(5):357-366.
6. Billings L.M., et al. Intraneuronal Abeta causes the onset of early Alzheimer's disease-related cognitive deficits in transgenic mice. Neuron 2005, 45:675-688.
7. Braak H., et al. Silver impregnation of Alzheimer's neurofibrillary changes counterstained for basophilic material and lipofuscin pigment. Stain. Technol. 1988, 63:197-200.
8. Brion J.P., et al. Transgenic expression of the shortest human tau affects its compartmentalization and its phosphorylation as in the pretangle stage of Alzheimer's disease. Am. J. Pathol. 1999, 154:255-270.
9. Chohan M.O., et al. Hyperphosphorylation-induced self assembly of murine tau: a comparison with human tau. J. Neural Transm. 2005, 112:1035-1047.
10. Dawson H.N., et al. Inhibition of neuronal maturation in primary hippocampal neurons from tau deficient mice. J. Cell Sci. 2001, 114:1179-1187.
11. Denk F., Wade-Martins R. Knock-out and transgenic mouse models of tauopathies. Neurobiol. Aging 2009, 30:1-13.
12. Duff K., et al. Characterization of pathology in transgenic mice over-expressing human genomic and cDNA tau transgenes. Neurobiol. Dis. 2000, 7:87-98.
13. Fic E., et al. Comparison of protein precipitation methods for various rat brain structures prior to proteomic analysis. Electrophoresis 2010, 31:3573-3579.
14. Gallyas F. Silver staining of Alzheimer's neurofibrillary changes by means of physical development. Acta Morphol. Acad. Sci. Hung. 1971, 19:1-8.
15. Gotz J., et al. Somatodendritic localization and hyperphosphorylation of tau protein in transgenic mice expressing the longest human brain tau isoform. EMBO J. 1995, 14:1304-1313.
16. Gotz J., et al. Formation of neurofibrillary tangles in P301l tau transgenic mice induced by Abeta 42 fibrils. Science 2001, 293:1491-1495.
17. Grimes C.A., Jope R.S. The multifaceted roles of glycogen synthase kinase 3beta in cellular signaling. Prog. Neurobiol. 2001, 65:391-426.
18. Hernandez F., Avila J. Tauopathies. Cell. Mol. Life Sci. 2007, 64:2219-2233.
19. Higuchi M., et al. Transgenic mouse model of tauopathies with glial pathology and nervous system degeneration. Neuron 2002, 35:433-446.
20. Ishihara T., et al. Age-dependent emergence and progression of a tauopathy in transgenic mice overexpressing the shortest human tau isoform. Neuron 1999, 24:751-762.
21. Ishihara T., et al. Age-dependent induction of congophilic neurofibrillary tau inclusions in tau transgenic mice. Am. J. Pathol. 2001, 158:555-562.
22. Kampers T., et al. Assembly of paired helical filaments from mouse tau: implications for the neurofibrillary pathology in transgenic mouse models for Alzheimer's disease. FEBS Lett. 1999, 451:39-44.
23. Lewis J., et al. Enhanced neurofibrillary degeneration in transgenic mice expressing mutant tau and APP. Science 2001, 293:1487-1491.
24. Medeiros R., et al. The role of tau in Alzheimer's disease and related disorders. CNS Neurosci. Ther. 2011, 17:514-524.
25. Mocanu M.M., et al. The potential for beta-structure in the repeat domain of tau protein determines aggregation, synaptic decay, neuronal loss, and coassembly with endogenous Tau in inducible mouse models of tauopathy. J. Neurosci. 2008, 28:737-748.
26. Oddo S., et al. Triple-transgenic model of Alzheimer's disease with plaques and tangles: intracellular Abeta and synaptic dysfunction. Neuron 2003, 39:409-421.
27. Oddo S., et al. Abeta immunotherapy leads to clearance of early, but not late, hyperphosphorylated tau aggregates via the proteasome. Neuron 2004, 43:321-332.
28. Oddo S., et al. Genetically augmenting tau levels does not modulate the onset or progression of Abeta pathology in transgenic mice. J. Neurochem. 2007, 102:1053-1063.
29. Oddo S., et al. Blocking Abeta42 accumulation delays the onset and progression of tau pathology via the C terminus of heat shock protein70-interacting protein: a mechanistic link between Abeta and tau pathology. J. Neurosci. 2008, 28:12163-12175.
30. Otth C., et al. AbetaPP induces cdk5-dependent tau hyperphosphorylation in transgenic mice Tg2576. J. Alzheimers Dis. 2002, 4:417-430.
31. Probst A., et al. Axonopathy and amyotrophy in mice transgenic for human four-repeat tau protein. Acta Neuropathol. 2000, 99:469-481.
32. Querfurth H.W., LaFerla F.M. Alzheimer's disease. N. Engl. J. Med. 2010, 362:329-344.
33. Roberson E.D., et al. Reducing endogenous tau ameliorates amyloid beta-induced deficits in an Alzheimer's disease mouse model. Science 2007, 316:750-754.
34. Santacruz K., et al. Tau suppression in a neurodegenerative mouse model improves memory function. Science 2005, 309:476-481.
35. Shipton O.A., et al. Tau protein is required for amyloid {beta}-induced impairment of hippocampal long-term potentiation. J. Neurosci. 2011, 31:1688-1692.
36. Sydow, A., Mandelkow, E. M., 'Prion-like' propagation of mouse and human tau aggregates in an inducible mouse model of tauopathy. Neurodegener Dis. 7, 28-31.
37. Terwel D., et al. Axonal transport, tau protein, and neurodegeneration in Alzheimer's disease. Neuromol. Med. 2002, 2:151-165.
38. Tseng B.P., et al. Abeta inhibits the proteasome and enhances amyloid and tau accumulation. Neurobiol. Aging 2008, 29:1607-1618.
39. Wittmann C.W., et al. Tauopathy in Drosophila: neurodegeneration without neurofibrillary tangles. Science 2001, 293:711-714.